Centro de Investigación en Medicina Molecular e Enfermidades Crónicas (CIMUS)
Centro singular
Hospital Clinico Universitario de Valencia
Valencia, EspañaPublicacións en colaboración con investigadores/as de Hospital Clinico Universitario de Valencia (38)
2023
-
Cardiorenal benefits of finerenone: protecting kidney and heart
Annals of Medicine, Vol. 55, Núm. 1, pp. 502-513
-
Clinical Benefit of Bempedoic Acid in Randomized Clinical Trials
The American journal of cardiology, Vol. 205, pp. 321-324
-
Examining the association between exposome score for schizophrenia and cognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study
Psychiatry Research, Vol. 323
-
Finerenone: towards a holistic therapeutic approach to patients with diabetic kidney disease
Nefrologia, Vol. 43, Núm. 4, pp. 386-398
-
Impact of dapagliflozin on cardiac remodelling in patients with chronic heart failure: The DAPA-MODA study
European Journal of Heart Failure, Vol. 25, Núm. 8, pp. 1352-1360
-
Peripheral modulation of antidepressant targets MAO-B and GABAAR by harmol induces mitohormesis and delays aging in preclinical models
Nature Communications, Vol. 14, Núm. 1
-
The efficacy of intensive lipid-lowering therapies on the reduction of LDLc and of major cardiovascular events
Journal of Clinical Lipidology, Vol. 17, Núm. 5, pp. 602-611
2022
-
A genome-wide association study of survival in patients with sepsis
Critical Care, Vol. 26, Núm. 1
-
A replication study of JTC bias, genetic liability for psychosis and delusional ideation
Psychological Medicine, Vol. 52, Núm. 9, pp. 1777-1783
-
Evidence, and replication thereof, that molecular-genetic and environmental risks for psychosis impact through an affective pathway
Psychological Medicine, Vol. 52, Núm. 10, pp. 1910-1922
-
Examining facial emotion recognition as an intermediate phenotype for psychosis: Findings from the EUGEI study
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 113
-
Mortality and Heart Failure Risk Reductions in Patients Treated With Sacubitril-Valsartan in Clinical Trials
American journal of therapeutics, Vol. 29, Núm. 5, pp. e572-e575
-
The association between cannabis use and facial emotion recognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study
European Neuropsychopharmacology, Vol. 63, pp. 47-59
2021
-
Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings
Molecular Psychiatry, Vol. 26, Núm. 8, pp. 4529-4543
-
Examining the association between exposome score for schizophrenia and functioning in schizophrenia, siblings, and healthy controls: Results from the EUGEI study
European psychiatry : the journal of the Association of European Psychiatrists, Vol. 64, Núm. 1, pp. e25
-
Lipid lowering treatment in patients with very high risk cardiovascular disease. Spanish Society of Cardiology Consensus Document for the use of PCSK9 inhibitors in clinical practice
REC: CardioClinics, Vol. 56, Núm. 1, pp. 39-48
-
Long-term prognosis of women with Brugada syndrome and electrophysiological study
Heart Rhythm, Vol. 18, Núm. 5, pp. 664-671
-
Spread of a SARS-CoV-2 variant through Europe in the summer of 2020
Nature, Vol. 595, Núm. 7869, pp. 707-712
-
The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant
Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414
2020
-
1-(2′-Bromobenzyl)-6,7-dihydroxy- N-methyl-tetrahydroisoquinoline and 1,2-Demethyl-nuciferine as Agonists in Human D2 Dopamine Receptors
Journal of Natural Products, Vol. 83, Núm. 1, pp. 127-133